Bristol-Myers Second-Quarter Profit Falls on Plavix Sales Drop

Bristol-Myers Second-Quarter Profit Falls on Plavix Sales Drop

JB Reed/Bloomberg

Excluding loss of revenue from the blood thinner Plavix and Avapro, a hypertension drug, to generic rivals, sales rose by 8 percent to $3.59 billion, Bristol-Myers Squibb Co. said.